Artwork

Inhoud geleverd door Sam Parnell & Ivanna Rosendal, Sam Parnell, and Ivanna Rosendal. Alle podcastinhoud, inclusief afleveringen, afbeeldingen en podcastbeschrijvingen, wordt rechtstreeks geüpload en geleverd door Sam Parnell & Ivanna Rosendal, Sam Parnell, and Ivanna Rosendal of hun podcastplatformpartner. Als u denkt dat iemand uw auteursrechtelijk beschermde werk zonder uw toestemming gebruikt, kunt u het hier beschreven proces https://nl.player.fm/legal volgen.
Player FM - Podcast-app
Ga offline met de app Player FM !

Inventing New Endpoints with Richard Nkulikiyinka

49:47
 
Delen
 

Manage episode 382347581 series 3526489
Inhoud geleverd door Sam Parnell & Ivanna Rosendal, Sam Parnell, and Ivanna Rosendal. Alle podcastinhoud, inclusief afleveringen, afbeeldingen en podcastbeschrijvingen, wordt rechtstreeks geüpload en geleverd door Sam Parnell & Ivanna Rosendal, Sam Parnell, and Ivanna Rosendal of hun podcastplatformpartner. Als u denkt dat iemand uw auteursrechtelijk beschermde werk zonder uw toestemming gebruikt, kunt u het hier beschreven proces https://nl.player.fm/legal volgen.

Join us in a fascinating conversation with our special guests, Richard Nkulikiyinka, as we unravel how endpoints in trials are transforming and the significant role they play in determining trial efficiency. We also delve into innovations in oncology endpoints and discuss the challenges and opportunities in cardiovascular trials. Tune in as we explore the use of composite endpoints in heart failure trials and exciting functional endpoints that are potentially leading the way for approval studies.
We took a deep dive into the critical impacts of trial design and data collection on entire trial enterprises, emphasizing the importance of prospective validation. Richard shared intriguing insights about the changing landscape of trial design and its ripple effect on the industry. He gave an in-depth analysis of sodium-glucose co-transporter inhibitors and the revolutionary changes they brought to the standard of care through a series of trials. You wouldn't want to miss their take on the advantages of umbrella and basket trials and the essential role collaboration plays for their success.
In this riveting discussion, Richard also illuminated the transformative power of innovation and collaboration in clinical trials. We delved into the thrilling potential of cross-company collaboration in investigating the same patient population and the possible role of impartial brokers. Richard also sheds light on how AI and technological advancements could enhance clinical trial outcomes. Listen as they dissect the potential of AI in imaging, its role in streamlining assessment processes, offering real-time feedback, and reducing the burden on specialists. As we wrapped up, we examined how machine learning could make clinical trials more cost-effective by automating the adjudication of events in cardiovascular trials. This enlightening conversation is a treasure trove of insights into the dynamic world of clinical trials.

________
Reach out to Sam Parnell and Ivanna Rosendal
Join the conversation on our LinkedIn page

  continue reading

Hoofdstukken

1. Inventing New Endpoints with Richard Nkulikiyinka (00:00:00)

2. Innovating Endpoints in Clinical Trials (00:00:13)

3. Trial Design and Data Collection Impact (00:13:53)

4. Innovation and Collaboration in Clinical Trials (00:25:57)

5. AI's Potential in Clinical Trials (00:32:58)

6. Making Clinical Trials More Cost Effective (00:39:58)

66 afleveringen

Artwork
iconDelen
 
Manage episode 382347581 series 3526489
Inhoud geleverd door Sam Parnell & Ivanna Rosendal, Sam Parnell, and Ivanna Rosendal. Alle podcastinhoud, inclusief afleveringen, afbeeldingen en podcastbeschrijvingen, wordt rechtstreeks geüpload en geleverd door Sam Parnell & Ivanna Rosendal, Sam Parnell, and Ivanna Rosendal of hun podcastplatformpartner. Als u denkt dat iemand uw auteursrechtelijk beschermde werk zonder uw toestemming gebruikt, kunt u het hier beschreven proces https://nl.player.fm/legal volgen.

Join us in a fascinating conversation with our special guests, Richard Nkulikiyinka, as we unravel how endpoints in trials are transforming and the significant role they play in determining trial efficiency. We also delve into innovations in oncology endpoints and discuss the challenges and opportunities in cardiovascular trials. Tune in as we explore the use of composite endpoints in heart failure trials and exciting functional endpoints that are potentially leading the way for approval studies.
We took a deep dive into the critical impacts of trial design and data collection on entire trial enterprises, emphasizing the importance of prospective validation. Richard shared intriguing insights about the changing landscape of trial design and its ripple effect on the industry. He gave an in-depth analysis of sodium-glucose co-transporter inhibitors and the revolutionary changes they brought to the standard of care through a series of trials. You wouldn't want to miss their take on the advantages of umbrella and basket trials and the essential role collaboration plays for their success.
In this riveting discussion, Richard also illuminated the transformative power of innovation and collaboration in clinical trials. We delved into the thrilling potential of cross-company collaboration in investigating the same patient population and the possible role of impartial brokers. Richard also sheds light on how AI and technological advancements could enhance clinical trial outcomes. Listen as they dissect the potential of AI in imaging, its role in streamlining assessment processes, offering real-time feedback, and reducing the burden on specialists. As we wrapped up, we examined how machine learning could make clinical trials more cost-effective by automating the adjudication of events in cardiovascular trials. This enlightening conversation is a treasure trove of insights into the dynamic world of clinical trials.

________
Reach out to Sam Parnell and Ivanna Rosendal
Join the conversation on our LinkedIn page

  continue reading

Hoofdstukken

1. Inventing New Endpoints with Richard Nkulikiyinka (00:00:00)

2. Innovating Endpoints in Clinical Trials (00:00:13)

3. Trial Design and Data Collection Impact (00:13:53)

4. Innovation and Collaboration in Clinical Trials (00:25:57)

5. AI's Potential in Clinical Trials (00:32:58)

6. Making Clinical Trials More Cost Effective (00:39:58)

66 afleveringen

Alle afleveringen

×
 
Loading …

Welkom op Player FM!

Player FM scant het web op podcasts van hoge kwaliteit waarvan u nu kunt genieten. Het is de beste podcast-app en werkt op Android, iPhone en internet. Aanmelden om abonnementen op verschillende apparaten te synchroniseren.

 

Korte handleiding